Are you a private practice urologist looking to build your bladder cancer service lines? In this episode of the BackTable Urology Podcast, Dr. Tom Jayram, urologist from Nashville joins host Dr. Aditya Bagrodia to discuss the latest advancements in non-muscle invasive bladder cancer treatment. The conversation focuses on the unique experiences and practical considerations in managing this complex condition in the community setting.

---

This podcast is supported by:

Ferring Pharmaceuticals

https://www.ferring.com/home-classic/people-and-families/uro-uro-oncology/bladder-cancer/

---

SYNPOSIS

The two urologic oncologists share their decision-making process for different therapies such as BCG, gemcitabine-doxorubicin, and Adstiladrin. The conversation also touches on the challenges of integrating new technologies into practice, managing the BCG shortage, and the role of multidisciplinary care. They discuss patient-centered care and the potential for personalized treatment plans. Finally, Dr. Jayram reflects on the lessons he has learned from his own practice, offering a unique insight into the differences between academic and community urology.

---

TIMESTAMPS

00:00 - Introduction

04:47 - Community Practice and New Technologies

09:59 - Clinical Trials for Bladder Cancer Care

15:52 - Patient Referrals

29:27 - Exploring New Treatment Options

30:46 - Bladder Sparing Strategies

32:21 - BCG Treatment and Surveillance

47:04 - Implementation of New Therapies

54:27 - Future Directions

---

RESOURCES

Ferring Pharmaceuticals

https://www.ferring.com/